Chronic myelomonocytic leukemia in the light of the WHO proposals

Haematologica

Volumn 92, Issue 7, 2007, Pages 974-977

  Germing, Ulrich ^a   Strupp, Corinna ^a   Knipp, Sabine ^a   Kuendgen, Andrea ^a   Giagounidis, Aristoteles ^d   Hildebrandt, Barbara ^a   Aul, Carlo ^b   Haas, Rainer ^a   Gattermann, Norbert ^a   Bennett, John M ^c  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b ST JOHANNES HOSPITAL   (Germany)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d NONE

Author keywords

CMML; Myelodysplastic syndromes; Myeloproliferative syndromes; Prognosis; WHO classification

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER SURVIVAL; CHRONIC MYELOMONOCYTIC LEUKEMIA; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOGENETICS; DISEASE COURSE; FEMALE; HEMATOLOGICAL PARAMETERS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; MORPHOLOGY; SURVIVAL TIME; WORLD HEALTH ORGANIZATION; CLASSIFICATION; MYELOPROLIFERATIVE DISORDER;

CLASSIFICATION; HUMANS; LEUKEMIA, MYELOMONOCYTIC, CHRONIC; MYELOPROLIFERATIVE DISORDERS; WORLD HEALTH ORGANIZATION;

EID: 34548799662     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.11051     Document Type: Article

References (12)

1. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR. et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982; 51:189-99.
2. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick H, Sultan C, Cox C. The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperative Leukaemia Group. Br J Haematol 1994;87:746-54.
3. Germing U, Gattermann N, Minning H, Heyll A, Aul C: Problems in the classification of CMML-dysplastic versus proliferative type. Leuk Res 1998; 25:871-8.
4. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, Sanz M, Vallespi T, Hamblin T, Oscier D, Ohyashiki K, Toyama K, Aul C, Mufti G & Bennett J. Interna-tional scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997;89:2079-88.
5. Germing U, Gattermann N, Strupp C, Aivado M, Aul C. Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients. Leuk Res 2000;24:983-92.
6. Jaffe ES, Harris NE, Stein H, Vardiman JW, editors. Pathology and Genetics: tumors of haematolopoietic and Lymphoid Tissues. IARC Press; 2001.
7. Worsley A, Oscier DG, Stevens J, Darlow S, Figes A, Mufti GJ, et al. Prognos-tic features of chronic myelomonocytic leukaemia: a modified Bournemouth score gives the best prediction of survival. Br J Haematol 1988;68:17-21.
8. Gonzalez-Medina I, Bueno J, Torrequebrada A, Lopez A, Vallespi T, Massague I. Two groups of chronic myelomonocytic leukaemia: myelodysplastic and myeloprolifera-tive. Prognostic implications in a series of a single center. Leuk Res 2002; 26:821-4.
9. Onida F, Kantarjian HM, Smith TL, Ball G, Keating MJ, Estey EH, et al. Prognostic factors and scoring systems in chronic mye-lomonocytic leukemia: a retrospective analysis of 213 patients. Blood 2002;99:840-9.
10. Aul C, Gattermann N, Heyll A, Germing U, Derigs G, Schneider W: Primary myelo-dysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system. Leukemia 1992;6:52-9.
11. Germing U, Strupp C, Kuendgen A, Aivado M, Giagounidis A, Hildebrandt B, et al. Refractory anaemia with excess of blasts (RAEB): analysis of reclassification according to the WHO proposals. Br J Haematol 2006;132:162-7.
12. Germing U, Strupp C, Kuendgen A, Isa S, Knipp S, Hildebrandt B, et al. Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes. Haematologica 2006;91:1596-604.